Search
3 December 2014

Finalists of GenerationS have presented their projects to the investors in Singapore

November 27 was the last day of the RVC session acceleration program under the international format LOGA Group & Seed Forum in Singapore for biotech and medical companies. During the program its participants have expanded their professional relations with organizations and investors in Singapore, received training and mentoring support from leading experts in the Asia-Pacific region, and presented their projects at the international investment forum Seed Forum.

"The program in Singapore, organized jointly with LOGA Group & Seed Forum, became the next step in the GenerationS accelerator: several teams of finalists got the opportunity to present their projects to potential foreign investors, customers and partners from the countries of Southeast Asia, – commented Gulnara Bikkulova, RVC director of innovation markets. – The participants significantly improved the marketing strategies on their projects based on the results of the meetings, by including the Asian markets into them."

The program was developed with consideration of the needs of Russian biotehmed projects. It included visits to the offices of government agencies of Singapore: SPRING Singapore (The Standards, Productivity and Innovation Board, State Agency for Enterprise Development), A * STAR (Agency for Science, Technology and Research), The Intellectual Property Office of Singapore (IPOS). Within a short period of time the representatives of the companies got acquainted with opportunities offered by Singapore for the development and promotion of technology companies. One of the brightest impressions became a visit to the Intellectual Property Office of Singapore (IPOS), a member of the World Intellectual Property Organization (WIPO). Director of the Representative Office of IPOS, Canra Darusman, told the participants in detailes about the activities of the organization and possible interactions on patenting and commercialization of technologies developed in Russia.

Mentors introduced participants to the organization of start-ups in Asia, local acceleration programs, business development in Singapore and the innovation ecosystem. There were conducted several workshops on patenting and intellectual property protection, attraction of investors and partners to commercialization of the project, preparation of a business plan, creation of an attractive offer for investors and the ways of monetization. The participants prepared documents and worked out skills for investment presentation. The entrepreneurs worked with mentors of the TechInAsia accelerator, with a representative of the National University of Singapore accelerator, visited the Singapore biomedical park Biopolis (where ETPL is located).

The intervals between study visits, meetings with mentors and experts were filled with intense preparation for the final event of acceleration program – the speech at Seed Forum. General Director of Seed Forum Steiner Korsmo and Claus Gaasvig helped participants in this preparation. "After the accelerator BiotechMed in Tomsk we got the feeling that we became "other people" – now this feeling is repeated once again, it is another jump on a higher level," – said Alexander Sevastyanov, marketing director of "Sibneyro" LLC (the Brain Target project – a program that evaluates the characteristics of brain tumours based on CT and MRI scans).

Some project presented at the Seed Forum attracted attention of local investors and potential partners, and some program participants expressed the desire to develop their projects in Singapore: "During the final performance at the International Seed Forum and dialogues with investors, we have gained a lot of business contacts and realized that the key market for our project is the Asian market, – says Alexander Sevastyanov. – We have found partners to enter this market. The State Organization SPRING Singapore has expressed a desire to contribute to our development, and the representatives of the Propell Company – to become our investors."

You have successfully subscribed!
Keep me posted!
Signing up to our project's newsletter you agree to the Terms of Use